Results 11 to 20 of about 8,862,620 (337)

Leucoreduction of blood components. an effective way to increase blood safety? [PDF]

open access: yesBlood transfusion = Trasfusione del sangue, 2015
Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens
Bianchi, Maria   +6 more
core   +2 more sources

Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa. [PDF]

open access: yesTransfus Med, 2023
Blood and blood products are listed as one of the essential medicines by the World Health Organization (WHO). In addition to inadequate supply, most sub‐Saharan Africa (SSA) nations fail to meet their blood needs because many donated blood units are ...
Puerto-Meredith S   +7 more
europepmc   +2 more sources

An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety? [PDF]

open access: yesViruses, 2022
A widespread outbreak of Japanese encephalitis virus (JEV) was detected in mainland Australia in 2022 in a previous non-endemic area. Given JEV is known to be transfusion-transmissible, a rapid blood-safety risk assessment was performed using a simple ...
Hoad VC   +4 more
europepmc   +2 more sources

Impact of disasters on blood donation rates and blood safety: A systematic review and meta-analysis. [PDF]

open access: yesVox Sang, 2022
Timely and adequate access to safe blood forms an integral part of universal health coverage, but it may be compromised by natural or man‐made disasters.
Laermans J   +6 more
europepmc   +2 more sources

Pandemic blood donor demographics - Do changes impact blood safety? [PDF]

open access: yesTransfusion, 2021
COVID‐19 safety measures and possibly SARS‐CoV‐2 antibody testing may alter blood donor demography, which has the potential to alter blood safety. We characterized pre‐pandemic and pandemic rates of donor infectious disease marker (IDM) reactivity which ...
Vassallo RR, Bravo MD, Kamel H.
europepmc   +2 more sources

Viral metagenomics and blood safety

open access: yesTransfusion Clinique et Biologique, 2016
The characterization of the human blood-associated viral community (also called blood virome) is essential for epidemiological surveillance and to anticipate new potential threats for blood transfusion safety. Currently, the risk of blood-borne agent transmission of well-known viruses (HBV, HCV, HIV and HTLV) can be considered as under control in high ...
Sauvage, V., Eloit, M.
openaire   +3 more sources

Evaluation of the WHO global database on blood safety. [PDF]

open access: yesVox Sang, 2021
While the Global Database on Blood Safety (GDBS) helps to monitor the status of adequate and safe blood availability, its presence alone does not serve as a solution to existing challenges.
Kanagasabai U   +8 more
europepmc   +2 more sources

Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency. [PDF]

open access: yesVox Sang, 2021
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus, first identified in China at the end of 2019 and has now caused a worldwide pandemic.
Kiely P, Hoad VC, Seed CR, Gosbell IB.
europepmc   +2 more sources

Coronavirus Disease 2019: Coronaviruses and Blood Safety. [PDF]

open access: yesTransfus Med Rev, 2020
With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world.
Chang L, Yan Y, Wang L.
europepmc   +2 more sources

The development of a legal framework for blood donation and blood safety in China over 24 years. [PDF]

open access: yesBMC Health Serv Res, 2020
Background This study analyzes the regulation of and developments in blood donation in China from 1996 to 2019, and demonstrates the government’s efforts to improve blood safety.
Gao D, Li H, Wang K.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy